Sagimet Biosciences, Inc. Class A (SGMT)
NASDAQ:SGMT
Total Valuation
Sagimet Biosciences, Inc. Class A has a market cap or net worth of $170.33M. The enterprise value is $135.39M.
Market Cap$170.33M
Enterprise Value$135.39M
Share Statistics
Sagimet Biosciences, Inc. Class A has 32,017,612 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding32,017,612
Owned by Insiders10.84%
Owned by Institutions23.61%
Financial Efficiency
Sagimet Biosciences, Inc. Class A’s return on equity (ROE) is -0.46 and return on invested capital (ROIC) is -51.04%.
Return on Equity (ROE)-0.46
Return on Assets (ROA)-0.44
Return on Invested Capital (ROIC)-51.04%
Return on Capital Employed (ROCE)-0.51
Revenue Per Employee0.00
Profits Per Employee-3.65M
Employee Count14
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Sagimet Biosciences, Inc. Class A is ―. Sagimet Biosciences, Inc. Class A’s PEG ratio is -0.42.
PE Ratio―
PS Ratio0.00
PB Ratio1.72
Price to Fair Value1.72
Price to FCF-4.19
Price to Operating Cash Flow-3.77
PEG Ratio-0.42
Income Statement
In the last 12 months, Sagimet Biosciences, Inc. Class A had revenue of 0.00 and earned -51.04M in profits. Earnings per share was -1.58.
Revenue0.00
Gross Profit0.00
Operating Income-56.89M
Pretax Income-51.04M
Net Income-51.04M
EBITDA-56.89M
Earnings Per Share (EPS)-1.58
Cash Flow
In the last 12 months, operating cash flow was -45.65M and capital expenditures 0.00, giving a free cash flow of -45.65M billion.
Operating Cash Flow-45.65M
Free Cash Flow-45.65M
Free Cash Flow per Share-1.43
Dividends & Yields
Sagimet Biosciences, Inc. Class A pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.85
52-Week Price Change174.23%
50-Day Moving Average5.45
200-Day Moving Average7.02
Relative Strength Index (RSI)52.49
Average Volume (3m)373.69K
Important Dates
Sagimet Biosciences, Inc. Class A upcoming earnings date is May 20, 2026, After Close (Confirmed).
Last Earnings DateMar 11, 2026
Next Earnings DateMay 20, 2026
Ex-Dividend Date―
Financial Position
Sagimet Biosciences, Inc. Class A as a current ratio of 22.82, with Debt / Equity ratio of 0.07%
Current Ratio22.82
Quick Ratio22.82
Debt to Market Cap<0.01
Net Debt to EBITDA0.61
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Sagimet Biosciences, Inc. Class A has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Sagimet Biosciences, Inc. Class A EV to EBITDA ratio is -2.75, with an EV/FCF ratio of -3.43.
EV to Sales0.00
EV to EBITDA-2.75
EV to Free Cash Flow-3.43
EV to Operating Cash Flow-3.43
Balance Sheet
Sagimet Biosciences, Inc. Class A has $113.12M in cash and marketable securities with $78.00K in debt, giving a net cash position of $113.05M billion.
Cash & Marketable Securities$113.12M
Total Debt$78.00K
Net Cash$113.05M
Net Cash Per Share$3.53
Tangible Book Value Per Share$3.44
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Sagimet Biosciences, Inc. Class A is $26.22, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$26.22
Price Target Upside392.86% Upside
Analyst ConsensusStrong Buy
Analyst Count10
Revenue Growth Forecast―
EPS Growth Forecast-38.23%